INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	118,320	93,258	93,320	51,597	186,337	253,364
Market Cap Growth	-22.43%	-0.07%	80.86%	-72.31%	-26.46%	119.86%
Enterprise Value	115,012	89,287	87,747	118,105	125,455	246,925
Last Close Price	11850.00	9340.00	9340.00	15500.00	71200.00	104800.00
PE Ratio	12.37	5.78	8.23	-	1.98	-
PS Ratio	16.18	13.25	14.95	4.95	17.78	24.80
PB Ratio	0.73	0.58	0.65	0.37	0.82	3.25
P/TBV Ratio	0.73	0.58	0.66	0.49	1.05	3.28
EV/Sales Ratio	15.73	12.68	14.06	11.34	11.97	24.17
EV/EBITDA Ratio	11.78	-	-	-	-	-
EV/EBIT Ratio	12.94	-	-	-	-	-
EV/FCF Ratio	-64.81	-	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.06	0.06
Asset Turnover	0.05	0.05	0.04	0.05	0.06	0.11
Inventory Turnover	13.86	12.99	4.10	5.61	6.94	6.01
Quick Ratio	4.44	4.32	4.90	3.92	1.07	4.66
Current Ratio	4.52	4.38	5.36	4.39	1.15	4.73
Return on Equity (ROE)	6.00%	10.64%	8.39%	-63.67%	61.55%	-62.65%
Return on Assets (ROA)	-2.39%	-2.47%	-2.66%	-1.78%	-2.74%	-3.50%
Return on Capital (ROIC)	-2.41%	-2.50%	-2.70%	-1.95%	-3.14%	-4.15%
Earnings Yield	8.08%	17.29%	12.16%	-227.18%	50.51%	-17.79%
FCF Yield	-1.50%	-0.13%	-1.15%	-22.55%	-5.06%	-3.34%
Buyback Yield / Dilution	-	-17.33%	-134.70%	-21.34%	-44.57%	6.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.